Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: Results from the Prostate Cancer Prevention Trial

American Journal of Epidemiology

Volumn 167, Issue 8, 2008, Pages 925-934

  Kristal, Alan R ^a,b   Arnold, Kathryn B ^a   Schenk, Jeannette M ^a,b   Neuhouser, Marian L ^a   Goodman, Phyllis ^a   Penson, David F ^c   Thompson, Ian M ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Alcohol drinking; Diet; Dietary supplements; Prostatic hyperplasia

Indexed keywords

ANTIOXIDANT; FAT; FINASTERIDE; LYCOPENE; PLACEBO; POLYUNSATURATED FATTY ACID; PROTEIN; VITAMIN D; ZINC;

CANCER; DIET; DRINKING; PROTEIN; RISK FACTOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; HUMAN; INCIDENCE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN DIET; QUESTIONNAIRE; RED MEAT; RISK ASSESSMENT; RISK REDUCTION; VEGETABLE; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; DIET; DIETARY SUPPLEMENTS; FINASTERIDE; FOOD HABITS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NUTRITION SURVEYS; NUTRITIONAL STATUS; ODDS RATIO; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEINS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 41649119115     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm389     Document Type: Article

References (37)

1. Kirby RS. The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 2000;56:3-6.
2. Platz EA, Smit E, Curhan GC, et al. Prevalence of and racial/ethnic variation in lower urinary tract symptoms and non-cancer prostate surgery in U.S. men. Urology 2002;59:877-83.
3. Kortt MA, Bootman JL. The economics of benign prostatic hyperplasia treatment: a literature review. Clin Ther 1996;18:1227-41.
4. Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994;140:989-1002.
5. Chokkalingam AP, Pollak M, Filmore CM, et al. Insulin-like growth factors and prostate cancer: a population-based case control study in China. Cancer Epidemiol Biomarkers Prev 2001;10:421-8.
6. Dahle SE, Chokkalingam AP, Gao YT, et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002;168:599-604.
7. Kristal AR, Arnold KB, Schenk JM, et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. J Urol 2007;177:1395-400.
8. Chyou PH, Nomura AM, Stemmermann GN, et al. A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate 1993;22:253-64.
9. Rohrmann S, Giovannucci E, Willett WC, et al. Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. Am J Clin Nutr 2007;85:523-9.
10. Foster CS. Pathology of benign prostatic hyperplasia. Prostate 2000;9:4-14.
11. Troisi RJ, Weiss ST, Parker DR, et al. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991;17:669-77.
12. Eikelis N, Schlaich M, Aggarwal A, et al. Interactions between leptin and the human sympathetic nervous system. Hypertension 2003;41:1072-9.
13. Kramer G, Marberger M. Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 2006;16:25-9.
14. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24.
15. Satia-Abouta J, Patterson RE, Schiller RN, et al. Energy from fat is associated with obesity in U.S. men: results from the Prostate Cancer Prevention Trial. Prev Med 2002;34:493-501.
16. Neuhouser ML, Kristal AR, Patterson RE, et al. Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials. Nutr Cancer 2001;39:12-18.
17. Barry MJ, Floyd JF, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992;148:1549-57.
18. Stryker WS, Kaplan LA, Stein EA, et al. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 1988;127:283-96.
19. Levander OA. The need for measures of selenium status. J Am Coll Toxicol 1986;5:37-44.
20. Hunter DJ, Morris JS, Chute CG, et al. Predictors of selenium concentration in human toenails. Am J Epidemiol 1990;132:114-22.
21. Dixon LB, Subar AF, Weideroff L, et al. Carotenoid and tocopherol estimates from the NCI Diet History Questionnaire are valid compared with multiple recalls and serum biomarkers. J Nutr 2006;136:3054-61.
22. Brunner E, Stallone D, Janeja M, et al. Dietary assessment in Whitehall II: comparison of 7 d diet diary and food-frequency questionnaire and validity against biomarkers. Br J Nutr 2001;86:405-14.
23. Talegawkar SA, Johnson EJ, Carithers T, et al. Total α-tocopherol intakes are associated with serum α-tocopherol concentrations in African American adults. J Nutr 2007;137:2297-303.
24. Araki H, Watanabe H, Mishina T, et al. High-risk group for benign prostatic hypertrophy. Prostate 1983;4:253-64.
25. Lagiou P, Wuu J, Trichopoulou A, et al. Diet and benign prostatic hyperplasia: a study in Greece. Urology 1999;54:284-90.
26. Morrison AS. Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 1992;135:974-80.
27. Signorello LB, Tzonou A, Lagiou P, et al. The epidemiology of benign prostatic hyperplasia: a study in Greece. BJU Int 1999;84:286-91.
28. Koskimäki J. Association of dietary elements and lower urinary tract symptoms. Scand J Urol Nephrol 2000;34:46-50.
29. Gass R. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. Br J Urol 2002;90:649-54.
30. Rohrmann S, Smit E, Giovannucci E, et al. Association between serum concentrations of micronutrients and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey. Urology 2004;64:504-9.
31. Suzuki S, Platz EA, Kawachi I, et al. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 2002;75:689-97.
32. Platz EA, Rimm EB, Kawachi I, et al. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol 1999;149:106-15.
33. Kang D, Andriole GL, van de Vooren RC, et al. Risk behaviours and benign prostatic hyperplasia. BJU Int 2004;93:1241-5.
34. Gordon GG, Altman K, Southren AL, et al. Effect of alcohol (ethanol) administration on sex-hormone metabolism in normal men. N Engl J Med 1976;295:793-7.
35. Dorgan JF, Judd JT, Longcope C, et al. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding. Am J Clin Nutr 1996;64:850-5.
36. Landsberg L. Feast or famine: the sympathetic nervous system response to nutrient intake. Cell Mol Neurobiol 2006;26:495-506.
37. Kristal AR, Peters U, Potter JD. Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev 2005;14:2826-8.